Full metadata record
DC FieldValueLanguage
dc.creatorOcio, E.M. (Enrique M.)-
dc.creatorBringhen, S. (Sara)-
dc.creatorMartínez-López, J. (Joaquín)-
dc.creatorSan-Miguel, J.F. (Jesús F.)-
dc.creatorOliva, S. (Stefania)-
dc.creatorRodriguez-Otero, P. (Paula)-
dc.creatorLe-Roux, N. (Nadia)-
dc.creatorDong, Y. (Yvonne)-
dc.creatorDoroumian, S. (Severine)-
dc.creatorMace, S. (Sandrine)-
dc.creatorMateos, M.V. (María Victoria)-
dc.date.accessioned2023-04-18T09:38:48Z-
dc.date.available2023-04-18T09:38:48Z-
dc.date.issued2023-
dc.identifier.issn2572-9241-
dc.identifier.urihttps://hdl.handle.net/10171/65975-
dc.language.isoen-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.titlePhase 1b Study of Isatuximab in combination with bortezomib, cyclophosphamide, and dexamethasone in newly diagnosed, transplant-ineligible multiple myeloma patients-
dc.typeinfo:eu-repo/semantics/other-
dc.description.noteThis is an open access article distributed under the terms of the Creative Commons AttributionNonCommercial-ShareAlike 4.0 License,-
dc.identifier.doi10.1097/HS9.0000000000000829-
dadun.citation.number2-
dadun.citation.publicationNameHemaSphere-
dadun.citation.startingPagee829-
dadun.citation.volume7-
dc.identifier.pmid36751513-

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
556.56 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.